Trodelvy 180 MG vials
Ended Awarded
- Contract number
- SPE2DB25FJ4RL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,377
Award facts
- Contract value 100% obligated
- $14,376.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,376.87 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Trodelvy 180 mg vials, with completion scheduled for September 26, 2025. This non-set-aside competitive award was fulfilled by AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania, the company's headquarters. Trodelvy (sacituzumab govitecan) is a therapeutic antibody-drug conjugate used primarily in oncology treatment, reflecting the Defense Logistics Agency's continued procurement of specialized pharmaceutical products for military healthcare systems.
This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The firm's substantial contract portfolio with the Defense Logistics Agency demonstrates its role as a critical vendor within the federal medical supply chain, particularly for the Department of Defense's healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FJ4RL?
SPE2DB25FJ4RL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FJ4RL worth?
The government has obligated $14,377 on SPE2DB25FJ4RL.
Is contract SPE2DB25FJ4RL an order under another contract?
Yes. SPE2DB25FJ4RL is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ4RL competed?
The extent of competition for SPE2DB25FJ4RL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award